Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

URGN

UroGen Pharma Ltd.

CIK 0001668243 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$38.56
↓ 1.67 (-4.15%)
as of Jul 10, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Technicals, Options; Risks: Ownership

Key stats

Market Cap
$1.96B
P/E Ratio
-14.71
EPS
-3.19
Dividend Yield
Not covered
52W Position
93%
Beta
1.25

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
-15.77
P/S
13.95
EV/Revenue
14.52
ROE
107.2%
Valuation data covers 8,503/9,467 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 93%
$13.55$40.34

Latest Financials

2025-12-31 FY
Revenue
$109.79M
Net Income
-$153.49M
Total Assets
$200.46M
Free Cash Flow
-$162.73M

Recent news